BASF's Pricing Push Meets the Agribusiness Carve-Out: A Balancing Act for the Second Half

BASF raises chemical prices, cuts costs, and plans agribusiness IPO to boost margins and reduce debt amid restructuring.

The chemicals giant is running two campaigns simultaneously — one aimed at shoring up margins in its core specialty chemicals business through a fresh round of price increases, the other at preparing its agricultural solutions division for a stock market debut that could reshape the group's financial profile.

On the pricing front, BASF has announced higher prices for the polyalcohols neopentyl glycol and 1,6-hexanediol in Europe, alongside increases for neopentyl glycol in North America effective September 1. Caprolactam, polyamide 6 and copolyamide prices in North America are also set to rise at the start of next month. The company cites higher raw material costs and a tight supply-demand balance as justification for the moves.

The timing is no coincidence. BASF is mid-restructuring, with the Ludwigshafen site having fallen below 30,000 full-time positions in May for the first time since 1954. Globally, roughly 7,000 roles have been eliminated since the start of 2024, with the "CoreShift" program targeting fixed-cost reductions of up to 20 percent in the core business by 2029. Management is budgeting for €2.3 billion in cost savings by the end of 2026, against one-off expenses of around €1.9 billion.

The Market's Verdict Hangs on Price Discipline

Whether the share price can sustain its upward trajectory depends largely on whether BASF can actually enforce these price increases in the marketplace — or whether customers, facing a subdued demand environment, will look elsewhere. Success would underpin margins in the second half; failure would risk eroding the cost advantages gained from headcount reductions.

The stock currently trades at €51.60, roughly 24 percent above its 52-week low of €41.55 from October last year. Year-to-date, the shares have gained 16 percent and sit 6.4 percent above their 200-day moving average — a technical signal that the medium-term trend remains intact. A push toward the April high of €55.05 is conceivable if momentum persists.

Debt Reduction and the IPO Calculus

The restructuring effort is intertwined with a deleveraging story. BASF wants to bring net debt down meaningfully, with maturing bonds providing relief this year and scheduled prepayments of bonds and loans totaling €1.6 billion in nominal volume due in the third quarter of 2026. A share buyback program of up to €1 billion, launched just over three weeks ago, has been accompanied by a 1.3 percent gain in the stock — funded in part by proceeds from the sale of the Coatings division to Carlyle.

The agribusiness spin-off, valued by observers at between €20 billion and €30 billion, is the pivotal event. A successful listing would strengthen the deleveraging path; a delay or weaker-than-expected valuation would put pressure on the entire roadmap of buybacks, debt reduction and cost cutting.

Operational Momentum Provides a Buffer

The bull case rests on recent operating performance. Preliminary second-quarter 2026 figures showed EBITDA before special items of €2.4 billion, comfortably beating average analyst estimates. Revenue rose by €2.4 billion to €17.2 billion, driven by an 11.5 percent price increase and 7.3 percent volume growth. Management subsequently raised its full-year guidance to EBITDA before special items of €6.9 billion to €7.7 billion.

Investment continues in parallel: around €15 million is going into a new climate center at Limburgerhof, slated for completion in the first half of 2027, which will generate regulatory data for crop protection products. The rollout of digital tools such as xarvio CONNECT 2.0 signals that the agribusiness unit is being operationally upgraded ahead of its stock market debut — a move that could support the targeted valuation.

Skepticism from the Sidelines

Barclays struck a cautious note on the European chemicals sector in early August, expressing reservations about BASF, Lanxess and Solvay. The concern: structurally weak European demand cannot be permanently offset by price increases alone, particularly with Asian competitors offering cheaper alternatives. Persistent low water levels on the Rhine have also forced logistics adjustments, with BASF shifting transport toward rail and road — though the company says it does not expect any material impact on results.

The accelerated headcount reduction carries its own risks. Restructuring costs could spike in the near term, weighing on the newly improved outlook, while the planned transfer of service positions to India adds another layer of operational complexity. An economic downturn in key markets would hit both core chemicals and the valuation basis for the spin-off.

What to Watch

The immediate test is whether BASF can hold the line on polyalcohol and polyamide pricing without significant volume losses. If it can, the bull case — supported by ongoing cost cuts and the prospect of a leaner corporate structure — remains the more probable path. If pricing discipline cracks, the Barclays-style skepticism toward the sector gains traction.

The completion of the Limburgerhof climate center in the first half of 2027 will serve as a concrete checkpoint on how seriously BASF is taking regulatory preparation for its agribusiness IPO. Until then, pricing discipline in specialty chemicals remains the most immediate indicator for investors.